Access cutting-edge asthma treatment through this clinical trial at a research site in Hawthorne. Study-provided care at no cost to qualified participants.
Access asthma specialists in Hawthorne at no cost
This study follows strict safety protocols and ethical guidelines
All study-related asthma treatment provided free
This is a parallel, Phase 3, 2-arm study to evaluate the efficacy and long-term safety of dupilumab treatment in children 2 to \<6 years of age with uncontrolled asthma and/or recurrent severe asthmatic wheeze. The study will be conducted in 2 parts. Part A will be a 52-week, randomized, double-blind, placebo-controlled study to assess the safety and efficacy of dupilumab in children aged 2 to \<6 years old with uncontrolled asthma and/or recurrent severe asthmatic wheeze. At the end of Part A,
Sponsor: Sanofi
Check if you qualify for this asthma clinical trial in Hawthorne, NY
If you're searching for asthma treatment options in Hawthorne, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Hawthorne research site is actively enrolling participants for this clinical trial. You'll receive care from experienced asthma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.